Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220516054879N9Phase 3Completed
Phase 3, double-blind trial of sildenafil and dexpanthenol in surgical scar (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: SCAR scale assessment of wound healing, Scar spread and 7 more. Started Nov 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220516054879N9.